Literature DB >> 1726946

World Health Organization Consensus Committee recommendations concerning the diagnosis of BPH.

A T Cockett, Y Aso, L Denis, S Khoury, M Barry, C E Carlton, D Coffey, J Fitzpatrick, K Griffiths, T Hald.   

Abstract

The expert committees, which met in Paris in June 1991 under the patronage of WHO to establish a consensus concerning BPH, adopted the recommendations summarised in this report. Despite certain criticisms which can be made, these recommendations offer the advantage of simplicity and uniformity, thereby constituting a "universal language". This will facilitate comparison of patients and therapeutic results, both in everyday practice and in the course of clinical trials. These recommendations will be periodically re-evaluated in the light of clinical experience and technological progress.

Entities:  

Mesh:

Year:  1991        PMID: 1726946

Source DB:  PubMed          Journal:  Prog Urol        ISSN: 1166-7087            Impact factor:   0.915


  9 in total

1.  HIV status is an independent risk factor for reporting lower urinary tract symptoms.

Authors:  Benjamin N Breyer; Stephen K Van den Eeden; Michael A Horberg; Michael L Eisenberg; Donna Y Deng; James F Smith; Alan W Shindel
Journal:  J Urol       Date:  2011-03-21       Impact factor: 7.450

2.  Do adult men with untreated hypospadias have adverse outcomes? A pilot study using a social media advertised survey.

Authors:  Bruce Schlomer; Benjamin Breyer; Hillary Copp; Laurence Baskin; Michael DiSandro
Journal:  J Pediatr Urol       Date:  2014-02-24       Impact factor: 1.830

3.  Effect of sexually transmitted infections, lifetime sexual partner count, and recreational drug use on lower urinary tract symptoms in men who have sex with men.

Authors:  Benjamin N Breyer; Eric Vittinghoff; Stephen K Van Den Eeden; Bradley A Erickson; Alan W Shindel
Journal:  Urology       Date:  2011-10-02       Impact factor: 2.649

4.  Recreational urethral sounding is associated with high risk sexual behaviour and sexually transmitted infections.

Authors:  Benjamin N Breyer; Alan W Shindel
Journal:  BJU Int       Date:  2012-01-05       Impact factor: 5.588

5.  Do adult men with untreated ventral penile curvature have adverse outcomes?

Authors:  Vani Menon; Benjamin Breyer; Hillary L Copp; Laurence Baskin; Michael Disandro; Bruce J Schlomer
Journal:  J Pediatr Urol       Date:  2015-10-23       Impact factor: 1.830

6.  Measure once, cut twice--adding patient-reported outcome measures to the electronic health record for comparative effectiveness research.

Authors:  Albert W Wu; Hadi Kharrazi; L Ebony Boulware; Claire F Snyder
Journal:  J Clin Epidemiol       Date:  2013-08       Impact factor: 6.437

7.  Doxazosin added to single-drug therapy in hypertensive patients with benign prostatic hypertrophy.

Authors:  N Martell; M Luque
Journal:  J Clin Hypertens (Greenwich)       Date:  2001 Jul-Aug       Impact factor: 3.738

8.  Outcomes and quality of life issues in the pharmacological management of benign prostatic hyperplasia (BPH).

Authors:  Angelo J Cambio; Christopher P Evans
Journal:  Ther Clin Risk Manag       Date:  2007-03       Impact factor: 2.423

9.  α1-Blockers and 5α-Reductase Inhibitors Are the Most Recommended Drugs in Treating Benign Prostatic Hyperplasia: An Evidence-Based Evaluation of Clinical Practice Guidelines.

Authors:  Xiao-Feng Xu; Guo-Xiong Liu; Cong Zhu; Xi-Min Qiao; Shao-Fu Yu; Tong Deng; Ying-Hui Jin
Journal:  Front Pharmacol       Date:  2020-03-25       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.